Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Deferred Tax Assets and Related Valuation Allowances (Details)

v3.26.1
Schedule of Deferred Tax Assets and Related Valuation Allowances (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Reserves and other $ 1,421,000 $ 731,000
Net operating loss carry-forwards 29,455,000 27,869,000
Capitalized research and development 2,513,000 3,894,000
Research and development tax credit 2,479,000 2,205,000
Share-based compensation 1,877,000 1,430,000
Valuation Allowance (37,735,000) (36,129,000)
Net deferred tax asset